Market Synopsis of Global Cardiopulmonary Disease
Diagnostics and Treatment Market:
Market Scenario:
The
cardiopulmonary disease is used to describe a wide range of series of disorders
which affect the heart and the lungs. Cardiovascular disease is a universal
term for conditions affecting the heart or blood vessels. It's usually related
with a build-up of fatty deposits inside the arteries known as atherosclerosis.
It can also be related with an injury to arteries in organs such as the brain,
kidney, and heart. Respiratory disease is a medical term that includes extreme
conditions affecting the organs and tissues which make gas exchange possible in
higher organisms. Respiratory diseases range from mild to self-limiting, such
as the common cold, to life-threatening entities like bacterial pneumonia,
pulmonary embolism, and lung cancer.
Treatment
options vary depending on the type of cardiopulmonary disease present and may
include changes in diet or lifestyle, use of medications issued on prescription
or surgery. The most common cardiopulmonary diseases are hypertension, stroke,
and coronary heart disease. Untreated, cardiopulmonary diseases can be deadly.
Cardiopulmonary diseases are the major cause of death globally.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6390
The
substantial growth in the frequency of health conditions related to the lungs
and heart is the key factor to boosts the growth of this market. Also, the
increase in aged population and the rising frequency in cardiovascular and
respiratory diseases is also anticipated to drive the global market over the
forecast period. Exposure to nicotine, tobacco products, and others increases
the risk of obtaining cardiopulmonary diseases.
Increase
in the rise of advanced technological equipment’s for diagnosing the disease
will drive market rate exponentially. However, the huge cost of treatment and
the regulatory nature of government on pharmaceutical companies will hamper the
growth of the market.
Segmentation
The
global cardiopulmonary disease diagnostics and treatment market has been
segmented on the basis of disease type, type, and end-user.
On the
basis of disease type, the market has been classified as cardiovascular and
respiratory diseases. The cardiovascular diseases are segmented into coronary
artery disease, angina pectoris, myocardial infarction, dysrhythmia,
hypertension, and others. The respiratory diseases are segmented into
influenza, asthma, bronchitis, emphysema, cystic fibrosis, and others.
On the
basis of type, the market has been classified as diagnosis and treatment. The
diagnosis market is segmented into an electrocardiogram (ECG), Holter
monitoring, echocardiogram, stress test, cardiac catheterization, cardiac
computerized tomography (CT) scan, cardiac magnetic resonance imaging (MRI),
single-photon emission computed tomography (SPECT), stress blood pressure
monitors, pulse oximeters and spirometry. The treatment market is segmented
into medications. The medications segment is further sub-segmented into
angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor
blockers (ARBS), anticoagulants, antiplatelet agents and others.
On the
basis of end users, the market has been classified as hospitals, clinics,
diagnostic centers, specialty clinics and rehab centers, research institutes
and others.
On the
basis of region, the market is segmented into the Americas, Europe,
Asia-Pacific, and the Middle East and Africa. The Americas has been further
segmented into North America and South America, with the North American market
divided into the US and Canada.
The
European cardiopulmonary disease diagnostics and treatment market has been
segmented into Western Europe and Eastern Europe. Western Europe has further
been classified as Germany, France, the UK, Italy, Spain, and the rest of
Western Europe.
The
cardiopulmonary disease diagnostics and treatment market in Asia-Pacific has
been segmented into Japan, China, India, South Korea, Australia, and the rest
of Asia-Pacific. The cardiopulmonary disease diagnostics and treatment market
in the Middle East and Africa has been segmented into the Middle East and
Africa.
Regional
Market Summary
In the
cardiopulmonary disease diagnostics and treatment market, North America is
anticipated to account for the largest market share due to the early adoption
of advanced medical technologies, the rise in awareness, the rise in growth of
the healthcare sector, and due to favorable compensation setting for many
surgical procedures.
The
European market is expected to hold the second largest market share. The market
growth in this region can be attributed to rising frequency of cardiovascular
disorders, increasing number of surgeries and increasing demand for advanced
treatment procedures are boosting the European market.
The
market share in Asia-Pacific is also projected to experience growth in the near
future due to access to optimal treatment facilities and growing demand for
advanced technology, better adoption rate, increase in disposable income, and
rising medical tourism.
The
market in the Middle East and Africa is expected to account for the smallest
share of the global cardiopulmonary disease diagnostics and treatment market
due to an underdeveloped healthcare sector, lack of technical knowledge, and
poor medical facilities.
Key
Players
Some of
the key players in the global cardiopulmonary disease diagnostics and treatment
market are Cardinal Health, Cosmed Medical, GE Healthcare, Halma plc, Hill-Rom
Holdings, Inc., Koninklijke Philips N.V., MGC Diagnostics Corporation, NIHON
KOHDEN CORPORATION, Schiller AG, Masimo Corporation, and Vyaire Medical Inc.
Browse
Complete 85 Pages Premium Research
Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cardiopulmonary-disease-diagnostics-treatment-market-6390
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment